If you are in crisis, help is available now. Call or text 988 to reach the Suicide & Crisis Lifeline, or text HOME to 741741. If someone is in immediate danger, call 911. This site is information only and cannot provide urgent help.

ketaminenevada.com
Menu

Is Ketamine Therapy Legal in Nevada?

Yes. Ketamine is a federal Schedule III controlled substance, and physicians licensed in Nevada may prescribe and administer it — including off-label for depression, which means for a purpose the FDA has not formally approved.

The federal baseline

Ketamine and its mirror-image form esketamine are Schedule III controlled substances under federal law, which means they have accepted medical uses but can be misused. as of 18 Jul 2026 · U.S. Drug Enforcement Administration (source 1, opens in a new tab)Esketamine has no separate DEA listing; it is covered as an enantiomer of ketamine, and the Spravato label carries the CIII designation.

Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)

The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 4, opens in a new tab)

Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 5, opens in a new tab)

Nevada law: who may give it

Nevada advanced practice registered nurses have full practice authority: they may diagnose, treat and prescribe without physician supervision or a collaborative agreement, and because ketamine is Schedule III an APRN may prescribe it independently once controlled-substance registration is granted. Certified registered nurse anaesthetists are treated differently — Nevada law bars a CRNA from ordering or prescribing controlled substances except under physician supervision in a critical access hospital or a hospital in a town under 25,000 people, so in a Las Vegas or Reno clinic a CRNA may only administer ketamine on another prescriber's order. as of 18 Jul 2026 · Nevada Legislature (source 4, opens in a new tab)Nevada's two-year or 2,000-hour experience threshold applies to Schedule II prescribing only. Ketamine is Schedule III, so that threshold does not affect it.

Who may own a clinic in Nevada

Nevada restricts who may own a medical practice. State law bars a professional entity from issuing an ownership interest to anyone other than a natural person licensed in the same profession, so investor or lay ownership of a Nevada medical practice is not permitted and there is no healthcare exception. Nursing is not part of the medicine grouping, so an advanced practice nurse cannot co-own a Nevada entity organised to practise medicine. as of 18 Jul 2026 · Nevada Legislature (source 1, opens in a new tab)Whether Nevada hospitals may employ physicians is genuinely unsettled. A 2010 attorney general opinion found no express prohibition, and a 2023 bill to codify one was passed by the legislature and vetoed.

This matters to you only indirectly, but it shapes which clinics exist here and how they are structured.

Nevada Prescription Monitoring Program (NV PMP)

Prescription monitoring is where published information about ketamine most often goes wrong, because three different questions get collapsed into one. They have different answers.

What must be reported

Nevada's Prescription Monitoring Program is run by the State Board of Pharmacy. Every registered dispenser must upload details of any Schedule II, III, IV or V controlled substance dispensed for human use, no later than the end of the next business day. as of 18 Jul 2026 · Nevada Legislature (source 4, opens in a new tab)Many summaries say Schedules II to IV. The current statute says II to V.

When a prescriber must check

Nevada requires a practitioner to obtain and review a patient utilisation report before issuing an initial prescription for any Schedule II, III or IV controlled substance — and for a Schedule V opioid — then at least once every ninety days for as long as that treatment continues. The only exception covers cancer, sickle cell disease and hospice or palliative care, and only where getting the report would unreasonably delay care. as of 18 Jul 2026 · Nevada Legislature (source 4, opens in a new tab)

Does this apply to ketamine?

Partly, and Nevada is stricter here than several neighbouring states. Ketamine is Schedule III in Nevada, and Schedule III sits squarely inside the state's check requirement — so if a clinician writes you a ketamine prescription to take away, they must run the report first and again every ninety days. Whether the requirement reaches an infusion given entirely inside a clinic is unsettled, because the duty is written around issuing a prescription rather than administering a dose. as of 18 Jul 2026 · Nevada Legislature (source 4, opens in a new tab)No Nevada board guidance or court decision resolves the in-clinic administration question, so we do not present either answer as settled.

Telehealth

Nevada does not require an in-person examination before prescribing controlled substances by telehealth. State law allows the patient relationship to be established by telehealth where that is clinically appropriate, and treats the relationship as valid if you were examined in person or by telehealth within the previous six months. The clinician must hold a Nevada licence. as of 18 Jul 2026 · Nevada Legislature (source 8, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, and they require video — audio-only does not qualify for ketamine. Spravato cannot be prescribed for home use in any case.

Through 31 December 2026, clinicians registered with the DEA may prescribe controlled medicines such as ketamine after a video telemedicine visit, without an in-person examination first. as of 1 Jan 2026 · Drug Enforcement Administration (source 1, opens in a new tab)This is the fourth temporary extension. Each of the previous three was issued close to its expiry date, so the position may change late in 2026.

The DEA's proposed rule to create a special registration for prescribing controlled medicines by telemedicine, published on 17 January 2025, is still only a proposal and has not been finalised. as of 17 Jan 2025 · Drug Enforcement Administration (source 1, opens in a new tab)No final rule and no withdrawal notice has been published. A rule can also be shelved without a formal withdrawal, so this should not be read as a statement that the DEA intends to finalise it.

Two things are worth holding onto here. The federal flexibility has a hard end date and has been extended four times at short notice, so anything you read about telehealth ketamine access needs a date attached to it. And a stricter state rule still applies regardless of what federal law permits.

Spravato is a separate case entirely: it must be taken in a certified clinic under observation, so it cannot be prescribed for home use whatever the telehealth position is.

How to check a clinician before you book

  1. Go to the Nevada State Board of Medical Examiners licence lookup.
  2. Search by name, and confirm the licence is current and unrestricted.
  3. Look for disciplinary history. It is published for a reason, and it is the single most useful thing you can check in five minutes.
  4. If you are seeking Spravato specifically, confirm the clinic is REMS-certified using the official locator . No other directory, including ours, can tell you that.